State
73,817 recalls have nationwide distribution and so reach US Virgin Islands. 178 additional recalls listed US Virgin Islands specifically in their distribution scope.
Of the 178 recalls naming US Virgin Islands we have scored against our rubric, 12 (7%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 39 (22%) are Severe.
Which agencies issued them
These figures cover only the 178 recalls whose distribution notice names US Virgin Islands specifically. The 73,817 nationwide recalls listed below reach every state, so counting them here would make every state page show the same numbers.
Ameditech is recalling 492 ProScreen CLIA Waived Cup kits due to reduced reactivity for Clonazepam and Chlordiazepoxide.
Ameditech is recalling ProScreen 6 Panel Dip Drug Screen kits due to reduced reactivity for two specific benzodiazepine compounds.
Ameditech is recalling 82 kits of ProScreen 8 Panel Dip Cards because they may show reduced reactivity for two specific benzodiazepine compounds.
Ameditech is recalling 100 Thermo Fisher 8 Drug Cassettes because they may show reduced reactivity for two specific benzodiazepine compounds.
Philips is recalling 31 Ingenuity CT systems because the perfusion scan feature may be unavailable on specific software versions.
Ameditech is recalling Immutest 10 Pnl Drug Screen Cups because they may show reduced reactivity for two specific benzodiazepine compounds.
Ameditech is recalling ProScreen 10 Drug Panel Cassette Tests because they may show reduced reactivity for specific benzodiazepine compounds.
Ameditech is recalling ProScreen 7 Panel Dip Cards because they may show reduced reactivity for Clonazepam and Chlordiazepoxide.
Ameditech is recalling ProScreen 12 Panel Dip Cards because they may show reduced reactivity for Clonazepam and Chlordiazepoxide.
Rainbow Specialty & Health Products is recalling Dressit-X dental dressings because the labeling does not list the percentage of drug components.
Philips is recalling 177 Ingenuity Core 128 CT systems because the perfusion scan feature may be unavailable on specific software versions.
Ameditech is recalling ProScreen CLIA Waived Cup 6 Drugs kits because they may show reduced reactivity for Clonazepam and Chlordiazepoxide.
Ameditech is recalling 12-Panel Dip Drug Screen kits because they may show reduced reactivity for Clonazepam and Chlordiazepoxide.
Ameditech Inc is recalling 31,472 Benzodiazepine Strip Dip Card kits because they may show reduced reactivity for Clonazepam and Chlordiazepoxide.
Ameditech is recalling ImmuTest Cup 7-panel drug tests because they may show reduced reactivity for two specific benzodiazepine compounds.
Ameditech is recalling ProScreen 10 Panel Dip Cards because they may show reduced reactivity for Clonazepam and Chlordiazepoxide.
Ameditech is recalling 1,680 ProScreen CLIA Wvd 12 Panel Cup kits because they may show reduced reactivity for Clonazepam and Chlordiazepoxide.
Ameditech is recalling ProScreen 5 Panel Dip Cards because they may show reduced reactivity for Clonazepam and Chlordiazepoxide.
Ameditech is recalling Micro Screen 6 Panel Cup kits because they may show reduced reactivity for two specific benzodiazepine compounds.
Perrigo is recalling Equaline All Day Allergy tablets because they contain an impurity called cetirizine monosaccharide ester.
Ameditech is recalling 1,907 DrugCheck Waived 12 Panel Cup kits nationwide due to reduced reactivity for Clonazepam and Chlordiazepoxide.
Ameditech is recalling DrugSmart 12 Test Cups because they may show reduced reactivity for two specific benzodiazepine compounds.
Ameditech is recalling Immutest 12 Panel Cup kits because they may show reduced reactivity for Clonazepam and Chlordiazepoxide.
Ameditech is recalling 300 kits of the Thermo Fisher 6 Drug Cassette because the tests may show reduced reactivity for two specific benzodiazepine compounds.
Ameditech is recalling iCup DX 6 Panel drug tests because they may show reduced reactivity for two specific benzodiazepine compounds.